Anti-diarrheal
NDC 68016-301, Loperamide HCl, tablet, from Chain Drug Consortium.
- Product NDC
- 68016-301
- Status
- Listed
- Labeler
- Chain Drug Consortium
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076497
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68016-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOPERAMIDE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Opioid Agonist [EPC]; Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68016-301-18 | 68016030118 | 3 BLISTER PACK in 1 CARTON (68016-301-18) / 6 TABLET in 1 BLISTER PACK |
| 68016-301-24 | 68016030124 | 4 BLISTER PACK in 1 CARTON (68016-301-24) / 6 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68016-301 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68016-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68016-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.